dc.creator | Hruby, Victor J. | |
dc.creator | Cai, Minying | |
dc.creator | Morgan, Caurnel | |
dc.date.accessioned | 2023-05-03T13:33:42Z | |
dc.date.available | 2023-05-03T13:33:42Z | |
dc.date.issued | 1/3/2023 | |
dc.identifier.uri | https://hdl.handle.net/1969.1/197560 | |
dc.description.abstract | Compositions and methods for treating a depressive disorder or an anxiety disorder in a subject in need of such treatment are described herein. A therapeutically effective amount of a composition comprising a melanocortin 5 receptor (MC5R) peptide ligand according to the following: ##STR00001## in a pharmaceutically acceptable carrier is administered to the subject. Xaa can be Cha or Pro. The MC5R peptide is a selective MC5R antagonist, and administration thereof to the subject can treat the depressive or anxiety disorder with clinical improvement observed in a relatively short time. | en |
dc.language | EN | |
dc.publisher | United States. Patent and Trademark Office | en |
dc.rights | Public Domain (No copyright - United States) | en |
dc.rights.uri | http://rightsstatements.org/vocab/NoC-US/1.0/ | |
dc.title | Modulators Of Melanocortin Receptors For The Treatment Of Depression And Anxiety | en |
dc.type | Utility patent | en |
dc.format.digitalOrigin | reformatted digital | en |
dc.description.country | US | |
dc.contributor.assignee | Arizona Board of Regents on behalf of the Univerity of Arizona | en |
dc.contributor.assignee | Texas A&M University System | en |
dc.identifier.patentapplicationnumber | 16/876683 | |
dc.date.filed | 5/18/2020 | |
dc.publisher.digital | Texas A&M University. Libraries | |
dc.subject.cpcprimary | A61K 9/0019 | |
dc.subject.cpcprimary | A61K 9/7023 | |
dc.subject.cpcprimary | A61K 38/12 | |
dc.subject.cpcprimary | A61P 25/22 | |
dc.subject.cpcprimary | A61K 38/07 | |
dc.subject.cpcprimary | C07K 5/0202 | |
dc.subject.cpcprimary | A61K 9/0053 | |
dc.subject.cpcprimary | A61P 25/24 | |
dc.subject.cpcprimary | A61K 38/00 | |